Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Brain Tumor Pathology

Open Access 07-05-2024 | Bevacizumab | Correction

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment

Authors: Taketo Ezaki, Toshihide Tanaka, Ryota Tamura, Kentaro Ohara, Yohei Yamamoto, Jun Takei, Yukina Morimoto, Ryotaro Imai, Yuki Kuranari, Yasuharu Akasaki, Masahiro Toda, Yuichi Murayama, Keisuke Miyake, Hikaru Sasaki

Published in: Brain Tumor Pathology

Login to get access

Excerpt

Correction: Brain Tumor Pathology (2024) 41:61–72 https://doi.org/10.1007/s10014-024-00481-0 …
Metadata
Title
Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment
Authors
Taketo Ezaki
Toshihide Tanaka
Ryota Tamura
Kentaro Ohara
Yohei Yamamoto
Jun Takei
Yukina Morimoto
Ryotaro Imai
Yuki Kuranari
Yasuharu Akasaki
Masahiro Toda
Yuichi Murayama
Keisuke Miyake
Hikaru Sasaki
Publication date
07-05-2024
Publisher
Springer Nature Singapore
Published in
Brain Tumor Pathology
Print ISSN: 1433-7398
Electronic ISSN: 1861-387X
DOI
https://doi.org/10.1007/s10014-024-00485-w